Article Details
Retrieved on: 2024-02-21 16:36:30
Tags for this article:
Click the tags to see associated articles and topics
Summary
Bioptimus, started by ex-DeepMind and Owkin experts, aims to innovate biopharma with a universal AI model using deep learning, backed by investors like Alphabet Inc., to hasten biological research breakthroughs.
Article found on: www.trendhunter.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here